495 filings
Page 5 of 25
4
a2cec5iin79enr pp
19 Mar 21
Zosano Pharma / Steven Lo ownership change
6:13pm
S-8
x1gxi0ygt20jay
12 Mar 21
Registration of securities for employees
4:41pm
8-K
1cny1qjxdmi4p
11 Mar 21
Departure of Directors or Certain Officers
4:22pm
8-K
8tnqle9a
11 Mar 21
Zosano Pharma Reports Fourth Quarter and Fiscal Year 2020 Financial Results
4:10pm
8-K
50wk f5a2inrp
4 Mar 21
Other Events
4:07pm
8-K
amiy 3qso
22 Feb 21
Zosano Pharma Confirms NDA Resubmission Strategy Following Type A Meeting Minutes from FDA
8:37am
8-K
knyir1 8tvs3592qokb
1 Feb 21
Zosano Pharma Announces NDA Resubmission Plans Following Type A Meeting with FDA
8:11am
8-K
y1smp
6 Jan 21
Other Events
4:16pm
SC 13G/A
azb0h3pn2tl73
5 Jan 21
Zosano Pharma / SABBY MANAGEMENT ownership change
7:58am
8-K
b4r8oh851
4 Jan 21
Zosano Pharma Requests Type A Meeting with the FDA to
4:15pm
8-K
55pi04ei85r9mat6
13 Nov 20
Zosano Pharma Reports Third Quarter 2020 Financial Results
4:08pm
8-K
pthwzdxbsq5h1 q891h
21 Oct 20
Other Events
8:45am
8-K
8rhwtl
30 Sep 20
Other Events
5:24pm
8-K
i3e5b9ger
3 Sep 20
Other Events
5:21pm
424B5
hrbha dcxwl
1 Sep 20
Prospectus supplement for primary offering
5:22pm
8-K
blt44 o4i0varfz
31 Aug 20
Regulation FD Disclosure
4:30pm
424B5
46mikdrohjm
31 Aug 20
Prospectus supplement for primary offering
4:21pm
8-K
1ssb4
17 Aug 20
Other Events
4:20pm